I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Immunogenicity and safety of a booster dose of the hepatiti..:
Matthias Girndt
;
Manfred Plüer
;
Frank Dellanna
...
http://dx.doi.org/10.1080/21645515.2022.2136912. , 2022
Link:
https://doi.org/10.1080/21645515.2022.2136912
RT Journal T1
Immunogenicity and safety of a booster dose of the hepatitis B vaccine HepB-CpG (HEPLISAV-B®) compared with HepB-Eng (Engerix-B®) and HepB-AS04 (Fendrix®) in adults receiving hemodialysis who previously received hepatitis B vaccination and are not seroprotected: Results of a randomized, multicenter phase 3 study
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:324437a38aa74c678935dcdd0ddf3fc9&Exemplar=1&LAN=DE A1 Matthias Girndt A1 Manfred Plüer A1 Frank Dellanna A1 Ann K. Michelsen A1 Joachim Beige A1 Kai Toussaint A1 Hubert J. Wehweck A1 Michael Koch A1 Syrus Hafezi Rachti A1 Justus Faust A1 Hans-Peter Bosselmann A1 Oliver Witzke A1 Robert S. Janssen A1 the HBV-18 Study Investigators PB Taylor & Francis Group YR 2022 K1 cpg 1018 adjuvant K1 hepatitis b virus K1 vaccine K1 hemodialysis K1 immunogenicity K1 safety K1 Immunologic diseases. Allergy K1 RC581-607 K1 Therapeutics. Pharmacology K1 RM1-950 JF http://dx.doi.org/10.1080/21645515.2022.2136912 LK http://dx.doi.org/https://doi.org/10.1080/21645515.2022.2136912 DO https://doi.org/10.1080/21645515.2022.2136912 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)